GSK (GSK): news on Saturday 10 October 2026

The 19 stories

Each headline's own score, strongest first. Links go to the publisher.

• +7.5 GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen Fierce Pharma
  $800M R&D and manufacturing hub commitment.
• +7.5 GSK to expand its Montco operations, add more than 300 jobs Audacy
  Expansion adding over 300 jobs shows growth commitment in US.
• +7.3 Pennsylvania says GSK to invest more than $800 million in biopharma hub, create 300 jobs Reuters
  Reuters reports $800M Pennsylvania hub investment.
• +7.2 GSK investing $800 million to expand in Montgomery County The Mercury
  $800M Montgomery County expansion is positive investment news.
• +7.0 GSK sinks another $800M into its Pennsylvania operations FirstWord PHARMA
  Further $800M US investment signals confidence and capacity growth.
• +7.0 GSK commits $800M to build new Upper Merion facility as pharma investment surges The Business Journals
  New Upper Merion facility funded with $800M.
• +7.0 GSK to expand Pennsylvania presence with over $800M investment Seeking Alpha
  Over $800M expansion of Pennsylvania presence.
• +7.0 GSK to invest more than $800 million in Pennsylvania biopharma hub Traders Union
  Over $800M biopharma hub investment.
• +6.7 GSK Plans More Than $800 Million Expansion in Pennsylvania TOKENPOST
  Report of $800M expansion plans.
• +6.7 Gov. Shapiro secures over $800M investment from GSK to expand operations, creating over 300 new jobs WFMZ.com
  Government-backed $800M investment and new jobs.
• +6.7 GSK secures USD 750 million cancer rights. Goldman keeps GBp 1,860 target for GSK stock AD HOC NEWS
  Secures cancer rights; Goldman keeps target.
• +6.3 Chai Discovery, GSK Announce Collaboration Following Wet-Lab Evaluation Contract Pharma
  New AI collaboration after successful lab evaluation.
• +6.3 GSK (LSE:GSK) Back In Focus: Does The Nuvalent Agreement Strengthen Its Cancer Pipeline Today? Kalkine Media
  Nuvalent agreement may strengthen cancer pipeline.
• +6.2 Chai Discovery Announces Collaboration with GSK Following Successful Wet-Lab Evaluation Business Wire
  Collaboration announced following successful wet-lab evaluation.
• +6.0 GSK drinks in Chai Discovery’s AI models after wet-lab validation Fierce Biotech
  Gains access to Chai AI models after validation.
• +5.8 What's behind GSK's latest stock surge? Traders Union
  Coverage of a recent stock surge.
• +5.7 Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine months Endpoints News
  AI startup deal adds to GSK's discovery tools.
• +5.5 Chai adds GSK to its roster of pharma deals after positive lab tests FirstWord PHARMA
  GSK joins Chai deals after positive lab tests.
• +3.0 Can $2.5B restructuring plan lift GSK stock? Traders Union
  Restructuring plan discussed as possible share support.